Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis

The Centers for Disease Control and Prevention (CDC) is seeking a contractor to conduct two comprehensive market forecast analyses: one for a human West Nile virus (WNV) vaccine and one for an anti-WNV monoclonal antibody (mAb) for seasonal pre-exposure prophylaxis. The contractor will perform market forecasting, epidemiologic analyses, health economic modeling, stakeholder engagement, commercial assessments, financial analyses, and preparation of peer-reviewed publications. The period of performance is 12 months, from September 30, 2026, to September 29, 2027. Key aspects of the job include: • Conducting market forecast analyses for WNV vaccine and anti-WNV mAb • Developing transparent forecasting models with clearly documented assumptions and parameters • Integrating epidemiologic, demographic, clinical, commercial, pricing, reimbursement, and policy information into the analyses • Conducting stakeholder engagement, including structured interviews with public health, clinical, payer, and industry representatives • Producing technically sound reports, models, supporting documentation, and peer-reviewed manuscripts • Identifying technical risks and proposing realistic mitigation strategies